6 ways ADHD impacts daily life as Chris Packham presents documentary on the condition
Ahead of the release of his new documentary Inside Our ADHD Minds, broadcaster Chris Packham has criticised those who dismiss attention deficit hyperactivity disorder (ADHD) as a fad.
ADHD is a neurodevelopment condition that affects an estimated 2.6 million people in the UK, which influences how individuals experience, process, and respond to the world around them. While children and adults may show different symptoms, the underlying cause is the same: their brains function differently from those who are not neurodivergent.
Now 64-year-old Packham, who was diagnosed with autism at 44, is returning with a new instalment of his Inside Our Minds series. This time, he's met people living with ADHD, with the documentary premiering tonight at 9pm on BBC Two.
The naturalist and nature photographer told Good Morning Britain today: "There is a tendency these days for people to say, 'Well, I think I'm a little bit autistic, a little bit ADHD, a little bit OCD,' but these are real conditions that impact people's lives all of the time. They're not a little bit any of these things. They're full on these things all of the time.
"That can have quite a significant impact on their lives, particularly when they're young, and particularly, I have to say, if they are young females, girls and young women, where they're not getting the diagnosis in the time that they should, so that they can live happier and more fulfilled lives. So our mission here is to ask people to better understand these conditions so that we can make small changes in society to make all of our lives easier and more productive."
Speaking about people who casually claim to have ADHD symptoms without a diagnosis, he added: "Let's be clear, some of the traits that I have as an autistic person and people have as someone with ADHD, it is a spectrum condition, you may have some of those [traits], but they may not be impacting on your life in the same way that they do ours.
"In our programs, we ask our contributors, brave, bold people who speak out frankly about the difficulties and challenges these conditions present in their life. But also, I have to say, about the attributes that they confer on their capacity to do things. It's not all negative."
The NHS estimates that 3-4% of adults and 5% of children in the UK have ADHD, with many presenting symptoms such as difficulty concentrating, forgetting tasks (or everyday events like brushing your teeth) or struggling to manage your time.
The condition may also present itself in hyperactivity, such as feeling restless, having high energy levels, being more talkative or making impulsive decisions.
"ADHD can greatly impact individuals lives," Tom Howcroft, from the ADHD Foundation explains. "Understanding its impacts and implementing effective management strategies can greatly enhance daily functioning and overall wellbeing.
"Receiving an ADHD diagnosis offers valuable insights into personal behaviours and challenges. By recognising the multifaceted impact of ADHD and implementing personalised management strategies, individuals can enhance their daily functioning and quality of life."
Howcroft says ADHD can lead to difficulties with concentration, organisation, and completing tasks, which can impact your school or workplace performance.
The best practice for coping with times were you feel easily distracted is to break tasks down into more manageable chunks, advises Howcroft, so focus is only needed for a short period of time.
Techniques like the Pomodoro method (25 minutes working followed by a five-minute break) can be helpful.
ADHD can make forming and sustaining friendships difficult, Howcroft says, due to a lack of impulse control and hyperactivity. It can be useful to find support groups or a community of likeminded people who understand and perhaps even live with ADHD themselves.
Howcroft also recommends counselling and coaching that can provide tailored strategies to help deal with the process of coming to terms with a diagnosis and how to work with your neurodivergent brain.
Stress is an inevitable part of all our lives, but ADHD can lead to a heightened sense of low mood or anxiety. "Persistent stress can exacerbate ADHD symptoms, leading to heightened anxiety and potential depressive symptoms," Howcroft explains.
In these circumstances, try to take regular breaks to ground yourself and alleviate these feelings by going for a walk, doing exercise, spending time outside or with loved ones.
ADHD can also lead to "repeated challenges and misunderstandings, such as perceived failures due to impulsiveness or disorganisation which can impact self-confidence and self-worth," says Howcroft.
If you have ADHD, it's important to practice self-compassion and focus on leaning into how your brain works to reframe ADHD-related struggles.
ADHD has also been known to lead to "struggles with planning, prioritising and completing tasks, which can affect personal and professional responsibilities," Howcroft says.
It can often help to lean on productivity tools such as planners, reminders or apps such as Notion or Monday to organise your tasks and track responsibilities and upcoming deadlines. All of this preparation can help to reduce feelings of overwhelming or feeling flustered with juggling your workload or life admin.
"Individuals may experience 'time blindness' leading to difficulties in perceiving and managing time effectively," Howcroft continues. "Creating consistent daily schedules can provide structure and reduce uncertainty, aiding in task completion and time management."
Read more about ADHD:
Psychiatrist explains why we've seen surge in ADHD and depression (Wales online, 4-min read)
Living with undiagnosed ADHD felt like I was always chasing my tail (Yahoo Life UK, 8-min read)
Nadia Sawalha tearful as she reveals ADHD diagnosis on Loose Women (Yahoo Entertainment, 2-min read)
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
an hour ago
- Yahoo
Warning over measles risk during school holidays
Parents are being urged to make sure their children are vaccinated against measles ahead of the summer holidays as an outbreak continues to spread across the UK. Measles is one of the most contagious diseases in the world, but two doses of the MMR vaccine during childhood can offer lifelong protection. However, uptake of the vaccine in Britain is below recommended levels, and cases have been rising. Young children have the first dose of the vaccine when they are one year old and the second at between three years and four months and five years of age. There have been 420 measles cases in England so far this year, with 86 last month alone, figures from the UK Health Security Agency (UKHSA) reveal. Two thirds of the cases were in children under 10, and almost 40 per cent were in London. The capital has the lowest vaccination percentage in the country, with more than a quarter of the population going without full protection. Officials are concerned that the infection, which can lead to serious complications, spreads easily through the air via sneezes, coughs and exhalations. They said it could see an uptick when schools break up for the summer and children mingle during the holidays. Measles has an estimated 'R' number of around 18, which means that, on average, a single infected person passes the infection on to 18 others. Covid has a natural 'R' number of about three. Dr Vanessa Saliba, a consultant epidemiologist at UKHSA, said: 'It's essential that everyone, particularly parents of young children, check all family members are up to date with two MMR doses, especially if you are travelling this summer for holidays or visiting family. 'Measles cases are picking up again in England, and outbreaks are happening in Europe and many countries with close links to the UK. 'Measles spreads very easily and can be a nasty disease, leading to complications like ear and chest infections and inflammation of the brain, with some children tragically ending up in hospital and suffering life-long consequences. Nobody wants this for their child, and it's not something you want to experience when away on holiday.' People who have the two doses of the MMR vaccine, which are safe and effective, are not only protecting themselves but also helping protect others who are unvaccinated, such as young babies. Health officials said parents could check their child's 'red book', a national record given to parents or carers to document a child's health and development, to see if they are fully protected. Adults can check their vaccination status by contacting their GP or checking in the NHS app, although not everyone's complete immunisation data is live on the app. UKHSA said that cases in Europe had reached their highest level in almost three decades last year. A global increase in measles has led the agency to say it is concerned that this could mean people bring back the contagious disease to England after travelling over the summer. There were more than 127,000 cases of measles in Europe last year, according to global health leaders, the highest number since 1997. So far this year, outbreaks have been documented in France, Italy, Spain and Germany. Romania, Pakistan, India, Thailand, Indonesia and Nigeria currently have among the largest number of measles cases worldwide, according to a recent report by the World Health Organisation. Dr Amanda Doyle, the national director for primary care and community services at NHS England, said: 'The recent increase in cases seen in England and Europe should act as an important reminder to ensure your child is protected. 'Too many babies and young children are still not protected against the diseases, which are contagious infections that spread very easily and can cause serious health problems. 'MMR jabs are provided free as part of the NHS routine immunisation programme, and I would encourage all parents to act on invites or check vaccination records if they think they may have missed their child's vaccination.' Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Yahoo
an hour ago
- Yahoo
Bird flu cases detected in seagulls in Cumbrian town
BIRD flu has been detected in a West Cumbrian town. Whitehaven Harbour Commissioners have confirmed that bird flu cases have been confirmed in the town. It is reported that the cases are affecting seagulls at the harbour. People are warned to take precautions when visiting the area, especially if walking a dog around the harbour. A Whitehaven Harbour Commissioners spokesman said: "Positive cases of avian influenza (bird flu) have been reported in the Whitehaven Harbour area. "There's no need to panic, but we kindly ask everyone to follow DEFRA's safety advice." Members of the public are urged to keep dogs on the lead at all times; do not touch wild birds; do not feed the birds; and wash your hands thoroughly if you come into contact with birds or droppings. Whitehaven Harbour Commissioners added: "We know it can be upsetting to see sick or injured birds but please do not approach or handle them. "For birds found on the Harbour, contact our office at 01946 590515 – a team member will help, or you can leave a message. "For birds in the water, please call Whitehaven Marina at 01946 692435. Thanks for helping keep our wildlife and community safe." The NHS says that bird flu, or avian flu, is an infectious type of influenza that spreads among birds. In rare cases, it can affect humans. There are lots of different strains of the bird flu virus. Most of them don't infect humans. The NHS website states: "Plans are in place to manage any suspected cases of bird flu in the UK. "H5N8 and H5N1 bird flu have been found in some poultry, other captive birds and wild birds in the UK. "H5N6 has also been found in some wild birds in the UK, but this is a different strain to the H5N6 virus that has infected some people in China."


Time Business News
2 hours ago
- Time Business News
When to Choose Strattera Over Adderall
Attention-Deficit/Hyperactivity Disorder (ADHD) affects millions of people worldwide, leading to difficulties with focus, impulsivity, and hyperactivity. While stimulant medications like Adderall are often the first line of treatment, non-stimulant options such as Strattera (atomoxetine) can be a more appropriate choice in certain situations. Understanding when to choose strattera vs adderall involves evaluating factors such as the patient's medical history, potential side effects, risk of substance abuse, and overall treatment goals. When managing depression and anxiety, selecting the appropriate medication is crucial for effective treatment. Both medications in question are popular SSRIs that help balance serotonin levels in the brain, improving mood and emotional stability. In the middle of this discussion, Lexapro vs zoloft often arises as a common comparison due to their similar uses but distinct side effect profiles and dosing schedules. While some patients respond better to one, others may experience fewer adverse effects or more rapid relief with the alternative. Consulting a healthcare provider is essential to tailor the choice to individual needs and medical history. Strattera and Adderall are both approved by the FDA for treating ADHD but function in very different ways. Adderall is a stimulant composed of amphetamine salts that work by increasing the levels of dopamine and norepinephrine in the brain. This results in improved attention, reduced impulsivity, and greater overall concentration. On the other hand, Strattera is a selective norepinephrine reuptake inhibitor (NRI), which means it primarily boosts norepinephrine without significantly impacting dopamine levels. Unlike Adderall, Strattera is not a controlled substance and carries a much lower risk of abuse. One of the primary reasons to choose Strattera over Adderall is when there's a concern about substance misuse or a history of addiction. Adderall is a Schedule II controlled substance due to its high potential for abuse and dependency. For individuals with a history of substance use disorder, Adderall may pose a serious risk. Strattera, being non-stimulant and non-addictive, offers a safer alternative. It allows for effective ADHD management without the risk of reinforcing addictive behaviors, making it particularly useful in populations vulnerable to stimulant misuse. Many individuals with ADHD also suffer from comorbid mental health conditions like anxiety or depression. In such cases, Strattera may be a better option than Adderall. Stimulants like Adderall can exacerbate anxiety symptoms in some patients, leading to increased restlessness, jitteriness, or panic attacks. Strattera, on the other hand, has shown some efficacy in improving symptoms of anxiety and may also provide mild antidepressant effects due to its norepinephrine-enhancing properties. Choosing Strattera can help manage both ADHD and accompanying mood or anxiety disorders without worsening either condition. Adderall, especially the immediate-release version, has a relatively short duration of action, requiring multiple doses throughout the day. Even the extended-release versions may wear off by late afternoon or evening. In contrast, Strattera is taken once daily and offers 24-hour symptom coverage. This can be particularly advantageous for individuals who need consistent control over their ADHD symptoms throughout the day and into the evening. Students, working professionals, or parents managing multiple responsibilities might find this steady effect preferable to the peaks and troughs associated with stimulant medications. While stimulants are effective for many people, they also come with a host of potential side effects, including insomnia, appetite suppression, irritability, increased heart rate, and elevated blood pressure. For some individuals, these side effects can be intolerable or even dangerous, particularly if they have underlying cardiovascular issues. Strattera generally has a milder side effect profile and is not associated with the same degree of appetite suppression or cardiovascular stimulation. Although it has its own set of side effects, such as nausea or fatigue, these are often more manageable and tend to lessen over time. In some clinical scenarios, a non-stimulant medication like Strattera is the preferred first-line treatment. For example, in younger children (especially those under six years of age), stimulants may not be recommended due to potential side effects and lack of data on long-term safety. Pediatricians may opt for Strattera as a gentler initial approach. Additionally, parents who are concerned about the stigma or potential long-term effects of stimulant use may feel more comfortable starting their child on a non-stimulant option. Stimulants such as Adderall can interfere with sleep, especially if taken later in the day. Sleep disturbances are a common complaint among stimulant users and can contribute to irritability, mood swings, and worsening of ADHD symptoms. Strattera is less likely to cause sleep disruption and may even help improve sleep quality for some patients. For individuals who already struggle with insomnia or erratic sleep patterns, Strattera may be the better treatment choice. One of the key differences between Adderall and Strattera is how quickly they take effect. Adderall typically produces noticeable results within hours, making it ideal for patients seeking immediate symptom relief. Strattera, however, requires several days to weeks to build up in the system and reach full therapeutic effect. For patients and clinicians willing to adopt a slower, more gradual treatment approach, this delayed onset can be worthwhile, especially given Strattera's longer-term stability and lower side effect profile. Because Adderall is a controlled substance, it comes with regulatory burdens such as limited refills, stricter prescribing rules, and potential stigma. Some patients or caregivers may prefer a treatment that does not involve these complications. Strattera, being non-controlled, can be prescribed more freely and refilled more easily. This can improve medication adherence and reduce the hassle associated with frequent doctor visits or pharmacy restrictions. In some cases, clinicians may not be completely certain whether a patient's symptoms are primarily due to ADHD or another condition such as anxiety, depression, or trauma-related disorders. Since stimulants can exacerbate certain psychiatric symptoms or produce euphoria, starting with a non-stimulant like Strattera can be a safer way to assess a patient's response without clouding the diagnostic picture. If symptoms improve with Strattera, it may confirm that norepinephrine imbalance plays a role in the condition, guiding future treatment decisions. Choosing between Strattera and Adderall requires a personalized approach that considers the individual's medical history, lifestyle, comorbid conditions, and treatment preferences. While Adderall remains highly effective for many, Strattera presents a viable and often safer alternative for those with substance abuse risks, anxiety, sleep disturbances, or cardiovascular concerns. It is also a strong option for patients seeking all-day symptom coverage or those who prefer to avoid controlled substances. Consulting with a knowledgeable healthcare provider is crucial in determining which medication best aligns with the patient's needs and long-term goals. TIME BUSINESS NEWS